Clinical Trials in Houston

Showing 4181-4200 of 13,620 trials

PerQseal® Clinical Study

NCT05653336

The objective is to evaluate the safety and effectiveness of the PerQseal vascular closure device system when used to achieve haemostasis of common femoral arteriotomies created by 12 to 22 F sheaths (arteriotomy up to 26 F) in subjects undergoing percutaneous catheter-based interventional procedures.

Percutaneous Large Hole Vascular Closure

Vivasure Medical Limited149 participantsStarted Mar 2023

Scottsdale, Arizona, United States • La Jolla, California, United States • Bangor, Maine, United States +15 more locations

COMPLETEDPhase 2< 1 mile

Ixazomib Citrate and Lenalidomide After Stem Cell Transplant in Treating Patients With Newly Diagnosed Multiple Myeloma

NCT01718743

This phase II trial studies how well ixazomib citrate and lenalidomide after stem cell transplant work in treating patients with newly diagnosed multiple myeloma. Ixazomib citrate may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Biological therapies, such as lenalidomide, may stimulate the immune system in different ways and stop cancer cells from growing. Giving ixazomib citrate together with lenalidomide may be effective in treating multiple myeloma.

Hematopoietic Cell Transplantation RecipientPlasma Cell Myeloma

M.D. Anderson Cancer Center64 participantsStarted Dec 2012

Houston, Texas, United States

PerQseal® Clinical Study

Ixazomib Citrate and Lenalidomide After Stem Cell Transplant in Treating Patients With Newly Diagnosed Multiple Myeloma

Find Trials by Condition in Houston

Anakinra for the Reduction of CAR-T Toxicity in Patients With Relapsed or Refractory Large B-cell Lymphoma

Safety and Clinical Activity of KT-253 in Adult Patients with High Grade Myeloid Malignancies, Acute Lymphocytic Leukemia, Lymphoma, Solid Tumors

Vemurafenib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With BRAF V600 Mutations (A Pediatric MATCH Treatment Trial)

Single Step Lesion Annotation and Localization of Suspicious Breast Lesions

Study of Capivasertib + Docetaxel vs Placebo + Docetaxel as Treatment for Metastatic Castration Resistant Prostate Cancer (mCRPC)

Study of the Safety and Efficacy of MR-100A-01 in Approximately 1200 Healthy Women for up to 13 Cycles

Efficacy, Safety and Tolerability of the Combination of Tropifexor & Licogliflozin and Each Monotherapy, Compared With Placebo in Adult Patients With NASH and Liver Fibrosis.

Open Label PK, PD and DDI of Dotinurad and Allopurinol in Gout Patients with Hyperuricemia

Prospective Research in Infants With Mild Encephalopathy

Intermediate Expanded Access Protocol CNMAu8.EAP04

Multi-Center Study on Performance of the Ponto Implant System Using Minimally Invasive Ponto Surgery (in Adult Patients)

B244 Topical Spray for the Treatment of Pruritus in Adults With a History of Atopic Dermatitis

Efatutazone Dihydrochloride in Treating Patients With Previously Treated Myxoid Liposarcoma That Cannot Be Removed by Surgery

Inolitazone Dihydrochloride and Paclitaxel in Treating Patients With Advanced Anaplastic Thyroid Cancer

Trastuzumab Deruxtecan With Nivolumab in Advanced Breast and Urothelial Cancer

Anastrozole and Letrozole After Surgery for the Treatment of Stage I-III Breast Cancer

A Phase 1 Study of ADA-011 for Subjects With Advanced Solid Tumors

Islatravir and Methadone Pharmacokinetics (MK-8591-029)